Speed and accuracy are critical in drug development ... intelligence (AI) with deep learning and ‘omics’ analyses to discover novel, therapeutic and commercial food-derived peptides.

As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for ...

In the wake of broadly available AI tools, most technical and natural sciences fields are advancing rapidly. This is particularly true in biotechnology, where AI models power breakthroughs in drug ...

To wit: Y Combinator-backed Cambridge, U.K.-based ReactWise is using AI to speed up chemical manufacturing — a key step in bringing new drugs to market. Once a promising drug has been identified ...

Drug discovery and development has always been subject to a large degree of chance and serendipity. Now, artificial intelligence (AI) is promising to substantially boost the odds of identifying ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Prior research has suggested that drug-resistant ... developing or finding peptides has proven to be too slow to address the crisis. So researchers have turned to AI-based approaches to aid ...

Researchers from Stanford Medicine have discovered a naturally occurring molecule that may provide an alternative to the ...

Bicycle's bicyclic peptide drug discovery platform is designed to produce drug candidates that have targeting properties like antibodies but are much smaller molecules, making manufacturing and ...

Attempts over the years to design "small molecule" drugs that block them have been largely unsuccessful, so in recent years scientists have explored using peptides – small protein fragments ...

In addition, the Group's subsidiary Viva Biotech Shanghai was successfully restructured into a joint stock limited company on September 27, 2024, as the Group currently holds approximately 72.9% of ...